Meticillin-resistant Staphylococcus aureus (MRSA)

Agencies

Centers for Disease Prevention and Control (CDC)

• Infection Control Guidance: Preventing Methicillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities (2025)

European Centre for Disease Prevention and Control (ECDC)

• Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus (Eurosurveillance, 2014)

Professional societies

Asia-Pacific Society of Infection Control (APSIC)

• A handbook of Infection Control for the Asian Healthcare Work (2022)

Healthcare Infection Society (HIS) and Infection Prevention Society

• Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities (2021)

Infectious Diseases Society of America (IDSA)

• Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children (2011)

Society for Healthcare Epidemiology of America (SHEA) / Infectious Diseases Society of America (IDSA) / Association for Professionals in Infection Control and Epidemiology (APIC)

• SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update

EU/EEA countries

Belgium

• Recommendations for the prevention, control and management of patients carrying multidrug-resistant bacteria in healthcare settings (MDRO). Provisionary version-intermediate opinion (High Council for Health, 2017)
  French:Recommandations en matière de prévention, maîtrise et prise en charge des patients porteurs de bactéries multi-résistantes aux antibiotiques (MDRO) dans les institutions de soins. Version provisoire – Avis intermédiaire (Conseil Supérieur de la Santé, 2017)

Finland

• National guidelines on controlling multidrug-resistant bacteria (National Institute for Health and Welfare 2014) (Institute for Health and Wellbeing, 2014) 
  Swedish: Anvisning för förebyggande av smittspridning av multiresistenta mikroorganismer : Svensk översättning av originalversion publicerad år 2014  (Institutet för Hälsa och välbefinnandet)
  Finnish: Ohje moniresistenttien mikrobien Tartunnantorjunnasta (Terveyden ja hyvinvoinnin laitos, 2014) 
  
  (This document includes guidance for infection prevention and control of MRSA)

France

• Prevention of cross-transmission of emerging highly resistant bacteria (High Council for Public Health, 2013).
  Prévention de la transmission croisée des 'Bactéries Hautement Résistantes aux antibiotiques émergentes' (BHRe) (Haut Conseil de la Santé Publique, 2013)
  
  (This document includes guidance targeting MRSA)

Germany

• Recommendations on prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in medical and other care facilities (Robert Koch Institute, Commission for Hospital Hygiene and Infection Prevention, 2014)
  Empfehlungen zur Prävention und Kontrolle von Methicillinresistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen (Empfehlung der Kommission für Kranken-haushygiene und Infektionsprävention beim Robert Koch-Institut, 2014)

Hungary

• Guidance on the prevention of infections caused by multi-resistant pathogens,  (National Centre for Epidemiology, 2016)
  Módszertani levél a multirezisztens kórokozók által okozott fertőzések megelőzéséről, (Országos epidemiológiai központ, módszertani levél, 2016)

Ireland

• Prevention and Control Methicillin-Resistant Staphylococcus aureus (MRSA). National Clinical Guideline No. 2 (Health Protection Surveillance Centre, 2013)
  and
  Summary: Prevention and control Methicillin-Resistant Staphylococcus aureus (MRSA). National Clinical Guideline No. 2 (Health Protection Surveillance Centre, 2013)

Netherlands

• Meticillin-resistant Staphylococcus aureus (MRSA) (Working Group on Infection Prevention, Dutch National Institute for Public Health and the Environment, 2017)
  Meticilline-resistente Staphylococcus aureus (MRSA)  [AM1] (Werkgroep Infectie Preventie, Rijksinstituut voor Volksgezondheid en Milieu, 2017)

Portugal

• Prevention and Control of colonisation and infection of Meticillin-resistant Staphylococcus aureus in hospitals and inpatient care units (General Health Directorate, 2015) 
  Prevenção e Controlo de Colonização e Infeção por Staphylococcus aureus Resistente à Meticilina (MRSA) nos hospitais e unidades de internamento de cuidados continuados integrados ( Direção-Geral da Saúde, 2015

Slovakia

• Guidance for the diagnosis, prevention and control of infections by bacteria with clinically and epidemiologically important resistance mechanisms. (Slovakian Republic Ministry of Health, 2014)
  OU MZ SR pre diagnostiku a protiepidemické opatrenia pri výskyte bakteriálnych pôvodcov infekčných ochorení s klinicky a epidemiologicky významnými mechanizmami rezistencie (Ministerstva zdravotníctva Slovenskej republiky, 2014) 
  
  (This document includes guidance for infection prevention and control of MRSA)

Countries outside the EU/EEA

United Kingdom

• Implementation of modified admission MRSA screening guidance for NHS (Department of Health expert advisory committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), 2014)